Our board is voluntary and elected by members to serve a four year term under our Constitution.
Cathy joined the Board of Directors in 2014 and was elected as Company Secretary in 2016. She is also a member of the Remuneration and Governance & Nominations sub-committees. Cathy has had epilepsy since 2008. Her background is in journalism and having spent 19 years with BBC News, she set up her own media production company in 2009. Cathy was elected as Chairperson in December 2019.
Clare joined the Board of Epilepsy Ireland in 2017. Her interest in the work of Epilepsy Ireland emerged when her son was diagnosed with a rare form of epilepsy. She brings a wealth of experience gained in corporate strategy, finance, investments, marketing and fundraising. Clare is a director of Select Strategies, a management consultancy. She holds an MBA from the UCD Smurfit Graduate Business School and a Higher Diploma in Psychology from UCD.
Helen brings a wide range of knowledge and expertise from her work in the Charity sector. She was diagnosed with Epilepsy in 2015 and having joined the Board in 2021, is passionate about contributing to the mission of our organisation in achieving a society where no life is limited by Epilepsy
Mark has served on the Board since 1999 having initially become involved as a result of a family member’s epilepsy diagnosis. He was Chairman of the Board from 2013 to 2019. He has also served on the Finance & Audit sub-committee for several years and is a former Treasurer. Mark’s professional background is in technology, financial services and banking.
Paul Fahey is a qualified pharmacist and health informatics expert. Paul is also a qualified Company Director holding a Diploma in Company Direction from the Institute of Directors. He has been a pharmacy owner for 25 years and has completed an MSc. in Health Informatics from Trinity College Dublin. He served as the President of the Pharmaceutical Society of Ireland from 2011-2013. Paul is actively involved in FIP (International Pharmaceutical Federation) serving on its Technology Forum.
Anne joined the Board in 2021. She has a keen interest in management and living with the condition as her daughter was diagnosed with epilepsy in 2017. Her professional background is in science and she has a Master’s degree in Microbial Genetics and a Ph.D. in Environmental Science. She worked in the pharmaceutical industry both in Ireland and the USA and as a consultant in an Engineering Company. She has volunteered with a number of charities and schools both in Ireland and the USA in the areas of education, special needs and healthy parenting .
Prof. King is a recently retired Consultant Paediatric Neurologist from Children’s Health Ireland (CHI) at Temple St., Rotunda Hospital and Beaumont Hospital. She is a Professor in Paediatrics at University College Dublin, School of Medicine & Medical Science and has many publications in the field of Paediatric Neurology including “A Handbook of Neurological Investigations in Children”. Professor King has collaborated in several Genomic projects which have led to definite diagnoses, genetic counselling and personalised treatments for many Irish families.
Shane joined the Board of Epilepsy Ireland in 2021. He has also been a member of the Finance & Audit sub-committee since 2019. Shane has had epilepsy since 2015. He is a Chartered Accountant and a Chartered Tax Adviser and works as a Senior Tax Manager with the Irish Tax Institute. He has been involved in a range of charitable causes in the past, particularly in the area of mental health.
Finance & Audit sub-committee
The sub-committee assists and advise the Board on the organisation’s finances, business activities and strategic direction.
Voluntary Members: Michael Sheehy (Chair); Cathy Grieve; Paul Kehoe; Tony Rhatigan, Derek Heffernan, Shane O'Brien
Staff: CEO & Finance Manager
Nominations & Governance sub-committee
The sub-committee advises the Board on all matters of governance including on the composition of the board and board recruitment.
Voluntary Members: Mark Dowdall; Ambrose Kealy; Cathy Grieve
The sub-committee sets the CEO’s objectives, appraises and reports to the Board on performance and sets policy on management remuneration.
Voluntary Members: Mark Dowdall; Cathy Grieve; Derry Gray
Quality & Safety sub-committee
The sub-committee oversees accountability for quality, safety and risk management in our services and across the organisation.
Voluntary Members: Clare O'Dea; Mary Fitzsimons
Staff: CEO, Director of Services
Sustainability & Business Development sub-committee
The sub-committee assists, supports and advises the Board in ensuring that the organisation’s income generation activities are sufficient to meet the financial, strategic and operational needs of the organisation into the future.
Voluntary Members: Paul Kehoe, Clare O'Dea; Ambrose Kealy; Tony Caravousanos
Staff: CEO, Fundraising & Communications Manager
Epilepsy Ireland Management Team
Chief Executive, Peter Murphy
Director of Services, Tara Smith
Fundraising Manager, Stephen Lowry
Finance Manager, Andrew O’Dwyer
Training Manager, Paul Sharkey
Advocacy & Communications Manager, Patrick McGeoghegan: